| Secondary |
| Lymphoma |
32.9% |
| Prophylaxis |
18.0% |
| Product Used For Unknown Indication |
8.3% |
| Sarcoma |
7.3% |
| Folate Deficiency |
5.5% |
| Leiomyosarcoma |
3.7% |
| Liposarcoma |
3.7% |
| Synovial Sarcoma |
3.7% |
| Acute Lymphocytic Leukaemia |
2.7% |
| Acute Myeloid Leukaemia |
2.6% |
| Myelodysplastic Syndrome |
2.2% |
| Peripheral T-cell Lymphoma Unspecified |
1.8% |
| Follicle Centre Lymphoma, Follicular Grade I, Ii, Iii |
1.6% |
| Chronic Lymphocytic Leukaemia |
1.1% |
| Premedication |
1.1% |
| Infection Prophylaxis |
1.0% |
| Breast Cancer |
0.9% |
| Acute Monocytic Leukaemia |
0.7% |
| Antibiotic Prophylaxis |
0.7% |
| Acute Myeloid Leukaemia Recurrent |
0.6% |
|
| Disease Progression |
42.3% |
| Nervous System Disorder |
9.9% |
| Thrombocytopenia |
8.5% |
| Death |
7.0% |
| Thrombocytosis |
4.2% |
| Completed Suicide |
2.8% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
2.8% |
| Infection |
2.8% |
| Second Primary Malignancy |
2.8% |
| Sinusitis Fungal |
2.8% |
| Atrial Fibrillation |
1.4% |
| Bacteraemia |
1.4% |
| Febrile Neutropenia |
1.4% |
| Gastrointestinal Haemorrhage |
1.4% |
| Graft Versus Host Disease In Skin |
1.4% |
| Hypersensitivity |
1.4% |
| Intracranial Tumour Haemorrhage |
1.4% |
| Liver Injury |
1.4% |
| No Therapeutic Response |
1.4% |
| Paraesthesia |
1.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.8% |
| Lymphoma |
29.0% |
| Chronic Lymphocytic Leukaemia |
7.2% |
| Plasma Cell Myeloma |
5.5% |
| Non-hodgkin's Lymphoma |
4.5% |
| Prophylaxis |
3.1% |
| Breast Cancer |
2.0% |
| Colorectal Cancer Metastatic |
2.0% |
| Follicle Centre Lymphoma, Follicular Grade I, Ii, Iii |
1.8% |
| Sarcoma Metastatic |
1.7% |
| Acute Lymphocytic Leukaemia |
1.5% |
| Diffuse Large B-cell Lymphoma |
1.3% |
| Myelodysplastic Syndrome |
1.1% |
| Nausea |
1.1% |
| Ewing's Sarcoma |
1.0% |
| Sarcoma |
1.0% |
| Back Pain |
0.8% |
| Breast Cancer Metastatic |
0.8% |
| Germ Cell Cancer |
0.8% |
| Pneumonia |
0.8% |
|
| Pneumonitis |
53.8% |
| Death |
6.6% |
| Infection |
5.5% |
| Basal Cell Carcinoma |
4.4% |
| Thrombocytopenia |
3.3% |
| Vomiting |
3.3% |
| Acute Myeloid Leukaemia |
2.2% |
| Mucosal Inflammation |
2.2% |
| Pneumocystis Jirovecii Pneumonia |
2.2% |
| Rash Maculo-papular |
2.2% |
| Renal Failure |
2.2% |
| Venoocclusive Liver Disease |
2.2% |
| White Blood Cell Count Increased |
2.2% |
| Cardiac Arrest |
1.1% |
| Depression |
1.1% |
| Disease Progression |
1.1% |
| Ewing's Sarcoma |
1.1% |
| Febrile Neutropenia |
1.1% |
| Generalised Erythema |
1.1% |
| Haemorrhage Intracranial |
1.1% |
|
